merck

MUMBAI: In good news for diabetics, cheaper versions of a blockbuster drug — Januvia(Sitagliptin) — hit the market on Wednesday, with more expected soon. The growing anti-diabetes market, valued at about Rs 17,000 crore, is set to…

Generic versions of the diabetes drug from some major companies including Dr Reddy’s, Glenmark, Sun Pharma and JB Chemicals’ will hit the market this weekMUMBAI: In good news for diabetics, cheaper versions of a blockbuster drug, Januvia…

The oral anti-diabetes drug market is in for a major shake-up as Merck, Sharp & Dohme's (MSD's) Januvia is expected to go off patent this month. According to market research firm AIOCD, at least 50 Indian drug makers are jumping…